Rate My Professor Briohny Spencer

Spencer's research contributions center on pharmacology, with a focus on the repurposing of alpha-adrenoceptor antagonists for cancer treatment and other areas such as micronutrition and antibacterial agents. Her publications include "A Pilot retrospective analysis of alpha-blockers on recurrence in men with localised prostate cancer treated with radiotherapy" (Scientific Reports, 2020, cited 12 times), co-authored with J Hart and others; "Prazosin but not tamsulosin sensitises PC-3 and LNCaP prostate cancer cells to docetaxel" (Pharmacology, 2018, cited 12 times); "The role of α1-adrenoceptor antagonists in the treatment of prostate and other cancers" (International Journal of Molecular Sciences, 2016, cited 51 times), with M Batty and others; "Paradoxical effects of the autophagy inhibitor 3-methyladenine on docetaxel-induced toxicity in PC-3 and LNCaP prostate cancer cells" (Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, cited 23 times); "Essentiality of trace element micronutrition in human pregnancy: a systematic review" (Journal of Pregnancy and Child Health, 2015, cited 54 times), with J Vanderlelie and A Perkins; and "Antibacterial activity of β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin trimethoprim complexes" (American Journal of Microbiology, 2011, cited 10 times). She has also contributed to pharmacy education research, such as "Integrating patient-centred care by a blended learning approach; student perspectives of the virtual family model in pharmacy" (2013). Her work has garnered over 159 citations on Google Scholar, influencing fields of oncology pharmacology and maternal nutrition.